1 1852 151 RANDOMISED CLINICAL TRIAL: YOGA VS A LOW-FODMAP DIET IN PATIENTS WITH IRRITABLE BOWEL SYNDROME. BACKGROUND: IRRITABLE BOWEL SYNDROME IS THE MOST FREQUENT GASTROINTESTINAL DISORDER. IT IS ASSUMED THAT LIFESTYLE INTERVENTIONS MIGHT BE A RATIONAL TREATMENT APPROACH. AIM: TO EXAMINE THE EFFECT OF A YOGA-BASED INTERVENTION VS A LOW-FODMAP DIET ON PATIENTS WITH IRRITABLE BOWEL SYNDROME. METHODS: FIFTY-NINE PATIENTS WITH IRRITABLE BOWEL SYNDROME UNDERTOOK A SINGLE-BLIND, RANDOMISED CONTROLLED TRIAL INVOLVING YOGA OR A LOW-FODMAP DIET FOR 12 WEEKS. PATIENTS IN THE YOGA GROUP RECEIVED TWO SESSIONS WEEKLY, WHILE PATIENTS IN THE LOW-FODMAP GROUP RECEIVED A TOTAL OF THREE SESSIONS OF NUTRITIONAL COUNSELLING. THE PRIMARY OUTCOME WAS A CHANGE IN GASTROINTESTINAL SYMPTOMS (IBS-SSS). SECONDARY OUTCOMES EXPLORED CHANGES IN QUALITY OF LIFE (IBS-QOL), HEALTH (SF-36), PERCEIVED STRESS (CPSS, PSQ), BODY AWARENESS (BAQ), BODY RESPONSIVENESS (BRS) AND SAFETY OF THE INTERVENTIONS. OUTCOMES WERE EXAMINED IN WEEKS 12 AND 24 BY ASSESSORS "BLINDED" TO PATIENTS' GROUP ALLOCATION. RESULTS: NO STATISTICALLY SIGNIFICANT DIFFERENCE WAS FOUND BETWEEN THE INTERVENTION GROUPS, WITH REGARD TO IBS-SSS SCORE, AT EITHER 12 (DELTA = 31.80; 95%CI = -11.90, 75.50; P = .151) OR 24 WEEKS (DELTA = 33.41; 95%CI = -4.21, 71.04; P = .081). WITHIN-GROUP COMPARISONS SHOWED STATISTICALLY SIGNIFICANT EFFECTS FOR YOGA AND LOW-FODMAP DIET AT BOTH 12 AND 24 WEEKS (ALL P < .001). COMPARABLE WITHIN-GROUP EFFECTS OCCURRED FOR THE OTHER OUTCOMES. ONE PATIENT IN EACH INTERVENTION GROUP EXPERIENCED SERIOUS ADVERSE EVENTS (P = 1.00) AND ANOTHER, ALSO IN EACH GROUP, EXPERIENCED NONSERIOUS ADVERSE EVENTS (P = 1.00). CONCLUSIONS: PATIENTS WITH IRRITABLE BOWEL SYNDROME MIGHT BENEFIT FROM YOGA AND A LOW-FODMAP DIET, AS BOTH GROUPS SHOWED A REDUCTION IN GASTROINTESTINAL SYMPTOMS. MORE RESEARCH ON THE UNDERLYING MECHANISMS OF BOTH INTERVENTIONS IS WARRANTED, AS WELL AS EXPLORATION OF POTENTIAL BENEFITS FROM THEIR COMBINED USE. 2018 2 2653 47 YOGA IMPROVES OCCUPATIONAL PERFORMANCE, DEPRESSION, AND DAILY ACTIVITIES FOR PEOPLE WITH CHRONIC PAIN. BACKGROUND: CHRONIC PAIN IS A COMPLEX ACCUMULATION OF PHYSICAL, PSYCHOLOGICAL, AND SOCIAL CONDITIONS, THUS INTERVENTIONS THAT ADDRESS PAIN AND PROMOTE OCCUPATIONAL PERFORMANCE ARE NEEDED. A HOLISTIC INTERVENTION, WITH MIND AND BODY COMPONENTS, IS LIKELY NECESSARY TO BEST TREAT THE COMPLEXITIES OF CHRONIC PAIN. THUS, WE DEVELOPED AND TESTED A YOGA INTERVENTION FOR PEOPLE WITH CHRONIC PAIN. OBJECTIVES: IN A RANDOMIZED CONTROL TRIAL (RCT), PARTICIPANTS WITH CHRONIC PAIN WERE RANDOMIZED TO A YOGA INTERVENTION OR USUAL CARE GROUP. BETWEEN AND WITHIN GROUP DIFFERENCES FOR PRE-AND POST-OUTCOME MEASURE SCORES WERE ASSESSED FOR: OCCUPATIONAL PERFORMANCE, COMPLETION OF ACTIVITIES, AND DEPRESSION. METHODS: PILOT RCT WITH PARTICIPANT ALLOCATION TO 8 WEEKS OF YOGA OR USUAL CARE. BOTH GROUPS RECEIVED ONGOING MONTHLY SELF-MANAGEMENT PROGRAMMING. DATA WERE COLLECTED BEFORE AND AFTER THE 8-WEEK INTERVENTION. PARTICIPANTS WERE RANDOMIZED TO YOGA OR USUAL CARE AFTER BASELINE ASSESSMENTS. DEMOGRAPHICS WERE COLLECTED AND MEASURES INCLUDED: CANADIAN OCCUPATIONAL PERFORMANCE MEASURE (COPM) TO ASSESS OCCUPATIONAL PERFORMANCE; THE 15-ITEM FRENCHAY ACTIVITIES INDEX (FAI)(ACTIVITIES); AND THE 9-ITEM PATIENT HEALTH QUESTIONNAIRE (PHQ-9) FOR DEPRESSION. INDEPENDENT T-TESTS WERE USED TO ASSESS DIFFERENCES BETWEEN GROUPS. PAIRED T-TESTS WERE USED TO ASSESS DIFFERENCES BETWEEN PRE- AND POST 8-WEEK INTERVENTION FOR BOTH THE YOGA AND THE USUAL CARE GROUPS. PERCENT CHANGE SCORES AND EFFECT SIZES WERE CALCULATED. RESULTS: 83 PEOPLE WERE RECRUITED FOR THE STUDY AND COMPLETED BASELINE ASSESSMENTS; 44 INDIVIDUALS WERE RANDOMIZED TO YOGA AND 39 TO THE CONTROL GROUP. THE AVERAGE AGE OF ALL PARTICIPANTS WAS 51.4+/-10.5 YEARS, 68% WERE FEMALE; AND 60% HAD AT LEAST SOME COLLEGE EDUCATION. THERE WERE NO SIGNIFICANT DIFFERENCES IN DEMOGRAPHICS OR OUTCOME MEASURES BETWEEN GROUPS AT BASELINE OR 8 WEEKS; HOWEVER, THE STUDY WAS NOT POWERED TO SEE SUCH DIFFERENCES. INDIVIDUALS RANDOMIZED TO THE CONTROL GROUP DID NOT SIGNIFICANTLY IMPROVE IN ANY OUTCOME MEASURE OVER THE 8 WEEKS. THERE WERE SIGNIFICANT IMPROVEMENTS IN COPM PERFORMANCE AND COPM SATISFACTION SCORES FOR INDIVIDUALS RANDOMIZED TO THE YOGA GROUP; BOTH SCORES SIGNIFICANTLY IMPROVED. COPM PERFORMANCE IMPROVED BY 27% WITH A MODERATE TO LARGE EFFECT SIZE (3.66+/-1.85 VS 4.66+/-1.93, P < 0.001, D = 0.76). COPM SATISFACTION SIGNIFICANTLY IMPROVED BY 78% (2.14+/-2.31 VS. 3.80+/-2.50, P < 0.001) AND HAD A LARGE EFFECTS SIZE (D = 1.02). FAI SCORES IMPROVED, INDICATING INCREASED ACTIVITY OR ENGAGEMENT IN DAILY OCCUPATION DURING THE 8-WEEK INTERVENTION. SCORES INCREASED BY 5% (38.13+/-8.48 VS. 39.90+/-8.57, P = 0.024) WITH A SMALL EFFECT SIZE (D = 0.37). DEPRESSION SIGNIFICANTLY DECREASED FROM 13.21+/-5.60 TO 11.41+/-5.82, P = 0.041, WITH A SMALL EFFECT SIZE. CONCLUSION: DATA FROM THIS PILOT RCT INDICATE YOGA MAY BE AN EFFECTIVE THERAPEUTIC INTERVENTION WITH PEOPLE IN CHRONIC PAIN TO IMPROVE OCCUPATIONAL PERFORMANCE, INCREASE ENGAGEMENT IN ACTIVITIES, AND DECREASE DEPRESSION. OCCUPATIONAL THERAPY PRACTITIONERS MAY CONSIDER ADDING YOGA AS A TREATMENT INTERVENTION TO ADDRESS THE NEEDS OF PEOPLE WITH PAIN. 2019 3 97 27 A NONRANDOMIZED COMPARISON STUDY OF SELF-HYPNOSIS, YOGA, AND COGNITIVE-BEHAVIORAL THERAPY TO REDUCE EMOTIONAL DISTRESS IN BREAST CANCER PATIENTS. THE AUTHORS ASKED BREAST CANCER (BC) PATIENTS TO PARTICIPATE IN 1 OF 3 MIND-BODY INTERVENTIONS (COGNITIVE-BEHAVIORAL THERAPY (CBT), YOGA, OR SELF-HYPNOSIS) TO EXPLORE THEIR FEASIBILITY, EASE OF COMPLIANCE, AND IMPACT ON THE PARTICIPANTS' DISTRESS, QUALITY OF LIFE (QOL), SLEEP, AND MENTAL ADJUSTMENT. NINETY-NINE PATIENTS COMPLETED AN INTERVENTION (CBT: N = 10; YOGA: N = 21; AND SELF-HYPNOSIS: N = 68). RESULTS SHOWED HIGH FEASIBILITY AND HIGH COMPLIANCE. AFTER THE INTERVENTIONS, THERE WAS NO SIGNIFICANT EFFECT IN THE CBT GROUP BUT SIGNIFICANT POSITIVE EFFECTS ON DISTRESS IN THE YOGA AND SELF-HYPNOSIS GROUPS, AND, ALSO, ON QOL, SLEEP, AND MENTAL ADJUSTMENT IN THE SELF-HYPNOSIS GROUP. IN CONCLUSION, MIND-BODY INTERVENTIONS CAN DECREASE DISTRESS IN BC PATIENTS, BUT RCTS ARE NEEDED TO CONFIRM THESE FINDINGS. 2017 4 2173 30 THE EFFECTS OF YOGA ON DYSPNEA, SLEEP AND FATIGUE IN CHRONIC RESPIRATORY DISEASES. PURPOSE: THIS STUDY WAS CARRIED OUT TO FIND OUT THE EFFECTS OF YOGA APPLIED TO CHRONIC RESPIRATORY DISEASE PATIENTS ON DYSPNEA, SLEEP QUALITY AND FATIGUE. MATERIAL AND METHOD: THE STUDY WAS CONDUCTED BETWEEN MAY AND AUGUST 2020 AS A RANDOMIZED CONTROLLED STUDY. 'PERSONAL INFORMATION FORM', 'RESPIRATORY FUNCTIONS MONITORING FORM', 'COPD AND ASTHMA FATIGUE SCALE (CAFS), "ASTHMA AND COPD SLEEP IMPACT SCALE (CASIS)" AND MODIFIED MEDICAL RESEARCH COUNCIL DYSPNEA SCALE (MMRC) WERE USED IN DATA COLLECTION. RESULTS: WHEN THE POST-TEST MEAN SCORES OF THE PATIENTS IN THE EXPERIMENTAL AND CONTROL GROUP WERE COMPARED, IT WAS FOUND THAT CAFS, CASIS AND MMRC MEAN SCORES OF THE PATIENTS IN THE EXPERIMENTAL GROUP DECREASED POSITIVELY COMPARED TO THE PATIENTS IN THE CONTROL GROUP AND THE DIFFERENCE BETWEEN WAS FOUND TO BE STATISTICALLY SIGNIFICANT (P < 0.05). CONCLUSION: YOGA HAS BEEN FOUND TO REDUCE THE SEVERITY OF DYSPNEA AND FATIGUE AND IMPROVE SLEEP QUALITY IN CHRONIC RESPIRATORY DISEASES. 2021 5 2789 45 YOGA THERAPY FOR ABDOMINAL PAIN-RELATED FUNCTIONAL GASTROINTESTINAL DISORDERS IN CHILDREN: A RANDOMIZED CONTROLLED TRIAL. OBJECTIVES: THE AIM OF THE PRESENT STUDY WAS TO COMPARE EFFECTS OF 10 WEEKS OF YOGA THERAPY (YT) AND STANDARD MEDICAL CARE (SMC) ON ABDOMINAL PAIN AND QUALITY OF LIFE (QOL) IN CHILDREN WITH ABDOMINAL PAIN-RELATED FUNCTIONAL GASTROINTESTINAL DISORDERS (AP-FGIDS). METHODS: SIXTY-NINE PATIENTS, AGES 8 TO 18 YEARS, WITH AP-FGIDS, WERE RANDOMIZED TO SMC COMPLEMENTED WITH YT OR SMC ALONE. YT IS A MIXTURE OF YOGA POSES, MEDITATION, AND RELAXATION EXERCISES AND WAS GIVEN ONCE A WEEK IN GROUP SESSIONS. SMC CONSISTED OF EDUCATION, REASSURANCE, DIETARY ADVICE, AND FIBERS/MEBEVERINE, IF NECESSARY. PAIN INTENSITY (PAIN INTENSITY SCORE [PIS] 0-5) AND FREQUENCY (PAIN FREQUENCY SCORE [PFS] 0-4) WERE SCORED IN A PAIN DIARY, AND QOL WAS MEASURED WITH KIDSCREEN-27. FOLLOW-UP WAS 12 MONTHS. TREATMENT RESPONSE WAS DEFINED AS >/=50% REDUCTION OF WEEKLY PAIN SCORES. RESULTS: AT 1-YEAR FOLLOW-UP, TREATMENT RESPONSE WAS ACCOMPLISHED IN 58% OF THE YT GROUP AND IN 29% OF THE CONTROL GROUP (P = 0.01); NO SIGNIFICANT DIFFERENCES FOR OTHER TIME POINTS WERE FOUND. YT, AND NOT SMC, RESULTED IN A SIGNIFICANT REDUCTION OF PIS (P < 0.01) AND PFS (P < 0.01) AFTER 12 MONTHS. DURING THE STUDY, HOWEVER, YT WAS NOT SIGNIFICANTLY SUPERIOR COMPARED WITH SMC. SUBANALYSES FOR TIME POINTS DEMONSTRATED A SIGNIFICANT GREATER REDUCTION OF PIS AT 12 MONTHS IN FAVOR OF YT. NO DIFFERENCES WERE FOUND FOR QOL. YT WAS MORE EFFECTIVE IN THE REDUCTION OF REPORTED MONTHLY SCHOOL ABSENCE (P = 0.03). CONCLUSION: AT 1-YEAR FOLLOW-UP, YT IN ADDITION TO STANDARD CARE WAS SUPERIOR COMPARED WITH SMC ACCORDING TO TREATMENT SUCCESS, PIS, AND REDUCTION OF SCHOOL ABSENCE. YT, HOWEVER, WAS NOT SIGNIFICANTLY MORE EFFECTIVE IN IMPROVING PFS OR QOL, COMPARED WITH SMC. 2016 6 1046 38 EFFECTS OF YOGA ON ANXIETY AND DEPRESSION FOR HIGH RISK MOTHERS ON HOSPITAL BEDREST. BACKGROUND: AND PURPOSE: IN RECENT YEARS, YOGA PRACTITIONERS HAVE JOINED FORCES WITH MEDICAL PROGRAMS TO APPROACH PATIENTS' WELL-BEING HOLISTICALLY. THIS STUDY IS A RANDOMIZED CONTROLLED TRIAL TO ASSESS THE EFFECTS OF A SPECIALIZED ADAPTED YOGA PROGRAM ON ANXIETY AND DEPRESSION FOR HIGH-RISK EXPECTANT MOTHERS ON BEDREST IN A HOSPITAL SETTING. MATERIALS AND METHODS: SEVENTY-NINE PREGNANT SUBJECTS ON PHYSICIAN ORDERED HOSPITALIZED BEDREST WERE RANDOMIZED INTO TWO GROUPS: RECEIVING BIWEEKLY YOGA SESSIONS (INTERVENTION GROUP) OR RECEIVING NO YOGA (CONTROL GROUP). DATA COLLECTION TOOL WAS THE HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS) TO ASSESS OUTCOMES AFTER DELIVERY. RESULTS: YOGA, EVEN AS LITTLE AS THREE SESSIONS, SHOWED SIGNIFICANT IMPACT IN REDUCING ANXIETY AND DEPRESSION HIGH-RISK PREGNANT WOMEN ON HOSPITALIZED BEDREST. PERCEIVED ANXIETY AND DEPRESSION OVERALL SCORES WERE LOWER IN THE INTERVENTION GROUP THAN IN THE CONTROL GROUP (P < 0.001). CONCLUSION: RESULTS DEMONSTRATED THAT YOGA IS AN EFFECTIVE INTERVENTION TO DECREASE ANXIETY AND DEPRESSION IN HIGH-RISK ANTEPARTUM WOMEN ON HOSPITALIZED BEDREST. 2020 7 1446 48 INDIVIDUALIZED YOGA FOR REDUCING DEPRESSION AND ANXIETY, AND IMPROVING WELL-BEING: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: DEPRESSION AND ANXIETY ARE LEADING CAUSES OF DISABILITY WORLDWIDE. CURRENT TREATMENTS ARE PRIMARILY PHARMACEUTICAL AND PSYCHOLOGICAL. QUESTIONS REMAIN ABOUT EFFECTIVENESS AND SUITABILITY FOR DIFFERENT PEOPLE. PREVIOUS RESEARCH SUGGESTS POTENTIAL BENEFITS OF YOGA FOR REDUCING DEPRESSION AND ANXIETY. THE AIM OF THIS STUDY IS TO INVESTIGATE THE EFFECTS OF AN INDIVIDUALIZED YOGA INTERVENTION. METHODS: A SAMPLE OF 101 PEOPLE WITH SYMPTOMS OF DEPRESSION AND/OR ANXIETY PARTICIPATED IN A RANDOMIZED CONTROLLED TRIAL COMPARING A 6-WEEK YOGA INTERVENTION WITH WAITLIST CONTROL. YOGA WAS ADDITIONAL TO USUAL TREATMENT. THE CONTROL GROUP WAS OFFERED THE YOGA FOLLOWING THE WAITLIST PERIOD. MEASURES INCLUDED DEPRESSION ANXIETY STRESS SCALE (DASS-21), KESSLER PSYCHOLOGICAL DISTRESS SCALE (K10), SHORT-FORM HEALTH SURVEY (SF12), SCALE OF POSITIVE AND NEGATIVE EXPERIENCE (SPANE), FLOURISHING SCALE (FS), AND CONNOR-DAVIDSON RESILIENCE SCALE (CD-RISC2). RESULTS: THERE WERE STATISTICALLY SIGNIFICANT DIFFERENCES BETWEEN YOGA AND CONTROL GROUPS ON REDUCTION OF DEPRESSION SCORES (-4.30; 95% CI: -7.70, -0.01; P = .01; ES -.44). DIFFERENCES IN REDUCED ANXIETY SCORES WERE NOT STATISTICALLY SIGNIFICANT (-1.91; 95% CI: -4.58, 0.76; P = .16). STATISTICALLY SIGNIFICANT DIFFERENCES IN FAVOR OF YOGA WERE ALSO FOUND ON TOTAL DASS (P = .03), K10, SF12 MENTAL HEALTH, SPANE, FS, AND RESILIENCE SCORES (P < .01 FOR EACH). DIFFERENCES IN STRESS AND SF12 PHYSICAL HEALTH SCORES WERE NOT STATISTICALLY SIGNIFICANT. BENEFITS WERE MAINTAINED AT 6-WEEK FOLLOW-UP. CONCLUSION: YOGA PLUS REGULAR CARE WAS EFFECTIVE IN REDUCING SYMPTOMS OF DEPRESSION COMPARED WITH REGULAR CARE ALONE. FURTHER INVESTIGATION IS WARRANTED REGARDING POTENTIAL BENEFITS IN ANXIETY. INDIVIDUALIZED YOGA MAY BE PARTICULARLY BENEFICIAL IN MENTAL HEALTH CARE IN THE BROADER COMMUNITY. 2016 8 1571 34 MANAGEMENT OF MYOFASCIAL PAIN DYSFUNCTION SYNDROME WITH MEDITATION AND YOGA: HEALING THROUGH NATURAL THERAPY. AIMS AND OBJECTIVES: AIMS AND OBJECTIVES OF THE STUDY WERE TO STUDY THE EFFECTIVENESS OF RAJ-YOGA MEDITATION AND PRANAYAMA IN PATIENTS WITH MYOFASCIAL PAIN DYSFUNCTION SYNDROME (MPDS) AND COMPARED THE EFFECTS WITH ONGOING CONVENTIONAL NONINVASIVE TREATMENT MODALITIES. MATERIALS AND METHODS: THE STUDY COMPRISED 30 PATIENTS DIVIDED EQUALLY (10 EACH) INTO 3 GROUP, I.E., CONTROL GROUP (CONVENTIONAL, NONINVASIVE TREATMENT), EXPERIMENTAL A GROUP (CONVENTIONAL, NONINVASIVE TREATMENT WITH RAJ-YOGA MEDITATION THERAPY AND PRANAYAMA), AND EXPERIMENTAL B GROUP (RAJ-YOGA MEDITATION THERAPY AND PRANAYAMA ONLY). PARAMETERS SUCH AS PAIN, MOUTH OPENING, MANDIBULAR DEVIATION, INFLAMMATION, SWELLING, CLICKING, OCCLUSION, AND PSYCHOLOGIC EVALUATION SUCH AS ANXIETY, STRESS, AND DEPRESSION WERE ASSESSED BEFORE THE START OF THE STUDY AND AT WEEKLY INTERVALS FOR 3 MONTHS. RESULTS: POSTTREATMENT PAIN AND INFLAMMATION IMPROVED BOTH IN THE CONTROL GROUP AND EXPERIMENTAL A GROUP, BUT STATISTICALLY IT IS HIGHLY SIGNIFICANT IN THE EXPERIMENTAL A GROUP. FURTHERMORE, IT IS EFFECTIVE IMMEDIATELY AS WELL AS FOR A LONG PERIOD IN EXPERIMENTAL A GROUP. IMPROVEMENT IN MOUTH OPENING WAS STATISTICALLY HIGHLY SIGNIFICANT IN CONTROL GROUP BUT NOT IN THE EXPERIMENTAL GROUPS. POSTTREATMENT ANXIETY AND STRESS STATUS WAS IMPROVED WITH STATISTICALLY HIGHLY SIGNIFICANT RESULT IN THE EXPERIMENTAL A AND B. THE POSTTREATMENT DEPRESSION STATUS ALONG WITH MANDIBULAR DEVIATION, SWELLING, CLICKING, AND OCCLUSION HAS NOT IMPROVED SIGNIFICANTLY IN ANY OF THE GROUPS. INTERPRETATION AND CONCLUSION: RAJ-YOGA MEDITATION AND PRANAYAMA IN COMBINATION WITH CONVENTIONAL, NONINVASIVE, TREATMENT MODALITIES SHOWED PROMISING RESULTS IN MPDS PATIENTS AS COMPARED TO EITHER MODALITIES ALONE. 2018 9 2059 33 THE BENEFITS OF YOGA FOR RHEUMATOID ARTHRITIS: RESULTS OF A PRELIMINARY, STRUCTURED 8-WEEK PROGRAM. THE AIM OF THIS STUDY WAS TO MEASURE THE EFFECTS OF A BI-WEEKLY RAJ YOGA PROGRAM ON RHEUMATOID ARTHRITIS (RA) DISEASE ACTIVITY. SUBJECTS WERE RECRUITED FROM AMONG RA PATIENTS IN DUBAI, UNITED ARAB EMIRATES BY EMAIL INVITATIONS OF THE RA DATABASE. DEMOGRAPHIC DATA, DISEASE ACTIVITY INDICES, HEALTH ASSESSMENT QUESTIONNAIRE (HAQ), AND QUALITY OF LIFE (QOL) BY SF-36 WERE DOCUMENTED AT ENROLLMENT AND AFTER COMPLETION OF 12 SESSIONS OF RAJ YOGA. A TOTAL OF 47 PATIENTS WERE ENROLLED: 26 YOGA AND 21 CONTROLS. BASELINE DEMOGRAPHICS WERE SIMILAR IN BOTH GROUPS. PATIENTS WHO UNDERWENT YOGA HAD STATISTICALLY SIGNIFICANT IMPROVEMENTS IN DAS28 AND HAQ, BUT NOT QOL. OUR PILOT STUDY OF 12 SESSIONS OF YOGA FOR RA WAS ABLE TO DEMONSTRATE STATISTICALLY SIGNIFICANT IMPROVEMENTS IN RA DISEASE PARAMETERS. WE BELIEVE THAT A LONGER DURATION OF TREATMENT COULD RESULT IN MORE SIGNIFICANT IMPROVEMENTS. 2009 10 1833 33 PSYCHOLOGICAL WELLNESS, YOGA AND QUALITY OF LIFE IN PATIENTS AFFECTED BY SCHIZOPHRENIA SPECTRUM DISORDERS: A PILOT STUDY. SCHIZOPHRENIA IS A SERIOUS PSYCHIATRIC DISORDER CHARACTERIZED BY POSITIVE SYMPTOMS, NEGATIVE SYMPTOMS AND NEUROCOGNITIVE DEFICITS. THE AIM OF THIS STUDY WAS TO ESTIMATE RELATIONSHIPS BETWEEN WELLNESS, YOGA AND QUALITY OF LIFE IN PATIENTS AFFECTED BY SCHIZOPHRENIA SPECTRUM DISORDERS. PARTICIPANTS WERE 30 PATIENTS WITH A DIAGNOSIS OF SCHIZOPHRENIA IN CARE AT THE REHABILITATIVE PSYCHIATRY AND RESEARCH VILLA CHIARA CLINIC IN MASCALUCIA (CATANIA, ITALY), AFTER THAT RANDOMLY ASSIGNED TO TWO GROUPS. THE FIRST GROUP FOLLOWED THE EXPERIMENTAL TREATMENT WITH SETS OF YOGA EXERCISES CONDUCTED BY A YOGA TRAINER AND A PSYCHIATRIST OR A CLINICAL PSYCHOLOGIST EXPERT IN YOGA, WHILE A SECOND CONTROL GROUP WAS TREATED WITH USUAL CARE. THE RESULTS REVEALED A SIGNIFICANT DIFFERENCE, BEFORE AND AFTER TREATMENT, BETWEEN THE EXPERIMENTAL GROUP AND THE CONTROL GROUP IN QUALITY OF LIFE. 2019 11 2341 40 USE OF YOGA IN OUTPATIENT EATING DISORDER TREATMENT: A PILOT STUDY. BACKGROUND: INDIVIDUALS WITH RESTRICTIVE EATING DISORDERS PRESENT WITH CO-MORBID PSYCHIATRIC DISORDERS AND MANY ATTEMPT TO CONTROL SYMPTOMS USING STRENUOUS EXERCISES THAT INCREASE CALORIC EXPENDITURE. YOGA OFFERS A SAFE AVENUE FOR THE ENGAGEMENT IN PHYSICAL ACTIVITY WHILE PROVIDING AN OUTLET FOR DISEASE-ASSOCIATED SYMPTOMS. THIS STUDY SOUGHT TO EXAMINE USE OF YOGA PRACTICE IN AN OUTPATIENT SETTING AND ITS IMPACT ON ANXIETY, DEPRESSION AND BODY IMAGE DISTURBANCE IN ADOLESCENTS WITH EATING DISORDERS. METHODS: TWENTY ADOLESCENT GIRLS WERE RECRUITED FROM AN URBAN EATING DISORDERS CLINIC WHO PARTICIPATED IN WEEKLY YOGA CLASSES AT A LOCAL STUDIO, IN ADDITION TO STANDARD MULTIDISCIPLINARY CARE. YOGA INSTRUCTORS UNDERWENT TRAINING REGARDING THIS PATIENT POPULATION. PARTICIPANTS COMPLETED QUESTIONNAIRES FOCUSED ON ANXIETY, DEPRESSION AND BODY IMAGE DISTURBANCE PRIOR TO THE FIRST CLASS, AND FOLLOWING COMPLETION OF 6 AND 12 CLASSES. RESULTS: IN PARTICIPANTS WHO COMPLETED THE STUDY, A STATISTICALLY SIGNIFICANT DECREASE IN ANXIETY, DEPRESSION, AND BODY IMAGE DISTURBANCE WAS SEEN, INCLUDING: SPIELBERGER STATE ANXIETY MEAN SCORES DECREASED AFTER THE COMPLETION OF 7-12 YOGA CLASSES [47 (95%CI 42-52) TO 42 (95%CI 37-47), ADJ. P = 0.0316]; AS DID THE ANOREXIA NERVOSA SCALE [10 (95% CI 7-12) VS. 6 (95%CI 4-8), ADJ. P = .0004], SCORES ON BECK DEPRESSION SCALES [18 (95%CI 15-22) TO 10 (95%CI 6-14), ADJ. P = .0001], AND WEIGHT AND SHAPE CONCERN SCORES [16 (95%CI 12-20) TO 12 (95%CI 8-16), ADJ. P =0.0120] AND [31 (95%CI 25-37) TO 20 (95%CI 13-27), ADJ. P = 0.0034], RESPECTIVELY. NO SIGNIFICANT CHANGES IN BODY MASS INDEX WERE SEEN THROUGHOUT THE TRIAL. CONCLUSIONS: YOGA PRACTICE COMBINED WITH OUTPATIENT EATING DISORDER TREATMENT WERE SHOWN TO DECREASE ANXIETY, DEPRESSION, AND BODY IMAGE DISTURBANCE WITHOUT NEGATIVELY IMPACTING WEIGHT. THESE PRELIMINARY RESULTS SUGGEST YOGA TO BE A PROMISING ADJUNCT TREATMENT STRATEGY, ALONG WITH STANDARD MULTIDISCIPLINARY CARE. HOWEVER, WHETHER YOGA SHOULD BE ENDORSED AS A STANDARD COMPONENT OF OUTPATIENT EATING DISORDER TREATMENT MERITS FURTHER STUDY. 2016 12 1081 42 EFFECTS OF YOGA ON SEXUAL FUNCTION IN WOMEN WITH METABOLIC SYNDROME: A RANDOMIZED CONTROLLED TRIAL. INTRODUCTION: FEMALE SEXUAL DYSFUNCTION IS AN IMPORTANT PUBLIC HEALTH ISSUE; IT HAS A HIGH GLOBAL PREVALENCE, BUT NO EFFECTIVE AND SAFE TREATMENT OPTIONS. THE PREVALENCE OF SEXUAL DYSFUNCTION IS HIGHER IN WOMEN WITH METABOLIC SYNDROME THAN IN THE GENERAL POPULATION. AIM: THE AIM OF THIS STUDY WAS TO INVESTIGATE THE EFFICACY OF YOGA AS A TREATMENT FOR SEXUAL DYSFUNCTION IN WOMEN WITH METABOLIC SYNDROME. METHODS: IN THIS RANDOMIZED, CONTROLLED STUDY, 41 WOMEN WITH METABOLIC SYNDROME (AGE 30-60 YEARS) WERE ASSIGNED TO A 12-WEEK YOGA EXERCISE GROUP (N=20) OR A WAIT-LISTED CONTROL GROUP (N=21). MAIN OUTCOME MEASURES: PRIMARY END POINTS WERE CHANGES IN TOTAL AND INDIVIDUAL DOMAIN SCORES ON THE FEMALE SEXUAL FUNCTION INDEX. RESULTS: THE 12-WEEK YOGA INTERVENTION RESULTED IN SIGNIFICANT IMPROVEMENT IN AROUSAL (0.74+/-1.18 VS. 0.16+/-0.82, RESPECTIVELY; P=0.042) AND LUBRICATION (0.72+/-1.12 VS. 0.06+/-0.87, RESPECTIVELY; P=0.008) COMPARED WITH THE CONTROL GROUP. SYSTOLIC BLOOD PRESSURE SHOWED SIGNIFICANTLY GREATER IMPROVEMENT IN THE YOGA GROUP THAN IN THE CONTROL GROUP AT THE 12-WEEK FOLLOW UP (-3.5+/-13.7 VS. 2.0+/-14.7, RESPECTIVELY; P=0.040). CONCLUSION: THESE FINDINGS SUGGEST THAT YOGA MAY BE AN EFFECTIVE TREATMENT FOR SEXUAL DYSFUNCTION IN WOMEN WITH METABOLIC SYNDROME AS WELL AS FOR METABOLIC RISK FACTORS. 2013 13 277 31 ADDITIONAL PRACTICE OF YOGA BREATHING WITH INTERMITTENT BREATH HOLDING ENHANCES PSYCHOLOGICAL FUNCTIONS IN YOGA PRACTITIONERS: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND AND OBJECTIVE: THE PRACTICE OF YOGA IS ASSOCIATED WITH ENHANCED PSYCHOLOGICAL WELLBEING. THE CURRENT STUDY ASSESSED THE CORRELATION BETWEEN THE DURATION OF YOGA PRACTICE WITH STATE MINDFULNESS, MIND-WANDERING AND STATE ANXIETY. ALSO, WE EXAMINED IF AN ADDITIONAL 20 MIN OF YOGA BREATHING WITH INTERMITTENT BREATH HOLDING (EXPERIMENTAL GROUP) FOR 8 WEEKS WOULD AFFECT THESE PSYCHOLOGICAL VARIABLES MORE THAN REGULAR YOGA PRACTICE (CONTROL GROUP) ALONE. METHODS: ONE HUNDRED SIXTEEN SUBJECTS WERE RANDOMLY ASSIGNED TO EXPERIMENTAL (N = 60) AND CONTROL (N = 56) GROUPS. STATE MINDFULNESS ATTENTION AWARENESS SCALE (SMAAS), MIND-WANDERING QUESTIONNAIRE (MWQ) AND STATE ANXIETY INVENTORY WERE ADMINISTERED AT BASELINE AND AT THE END OF 8 WEEKS. RESULTS: BASELINE ASSESSMENT REVEALED A POSITIVE CORRELATION BETWEEN DURATION OF YOGA PRACTICE WITH SMAAS SCORES AND NEGATIVE CORRELATION WITH MWQ AND STATE ANXIETY SCORES. AT THE END OF 8 WEEKS, BOTH GROUPS DEMONSTRATED ENHANCED PSYCHOLOGICAL FUNCTIONS, BUT THE EXPERIMENTAL GROUP RECEIVING ADDITIONAL YOGA BREATHING PERFORMED BETTER THAN THE GROUP PRACTICING YOGA ALONE. CONCLUSION: AN ADDITIONAL PRACTICE OF YOGA BREATHING WITH INTERMITTENT BREATH HOLDING WAS FOUND TO ENHANCE THE PSYCHOLOGICAL FUNCTIONS IN YOUNG ADULT YOGA PRACTITIONERS. 2018 14 2833 31 YOGA'S EFFECT ON FALLS IN RURAL, OLDER ADULTS. BACKGROUND: UNINTENTIONAL FALLS AFFECT 30% OF PEOPLE OVER AGE 65 YEARS. YOGA HAS BEEN SHOWN TO IMPROVE BALANCE. WE DESIGNED THIS STUDY TO EXAMINE IF YOGA REDUCES FALLS. METHODS: WE CONDUCTED 16 SESSIONS OF HATHA YOGA OVER 8 WEEKS. PARTICIPANTS WERE RANDOMLY ASSIGNED TO PRACTICE 10MIN OF YOGA DAILY AT HOME IN ADDITION TO 5-MIN RELAXATION EXERCISES OR RELAXATION EXERCISES ONLY (CONTROL GROUP). RESULTS: OF THE 38 PARTICIPANTS COMPLETING THE INTERVENTION, 15 PARTICIPANTS REPORTED A TOTAL OF 27 FALLS IN THE 6-MONTHS BEFORE THE STUDY, COMPARED TO 13 PARTICIPANTS SUSTAINING 14 FALLS IN THE 6 MONTHS FROM THE START OF THE STUDY (P<0.047), WITHOUT DIFFERENCE BETWEEN YOGA HOME-EXERCISE AND HOME RELAXATION-ONLY GROUPS. COMPARED TO BASELINE SCORES, ALL PARTICIPANTS IMPROVED ON THE BERG BALANCE SCALE (53-54 OUT OF 56, P=0.002), THE FUNCTIONAL GAIT ASSESSMENT (22.9-25.8 OUT OF 30 POINTS, P<0.001), AND THE DYNAMIC GAIT INDEX (20.6-22.4 OUT OF 24 POINTS, P<0.001). RIGHT LEG STAND TIME IMPROVED FROM A MEAN OF 13.3S TO 17.1S (P=0.020) AND STANDING FORWARD REACH DISTANCE FROM 26.0CM TO 29.6CM (P<0.001). WITHOUT DIFFERENCE BETWEEN GROUPS. CONFIDENCE, WITH THE ACTIVITIES-SPECIFIC BALANCE CONFIDENCE SCALE, INCREASED IN THE YOGA HOME-EXERCISE GROUP (88%-93%, P=0.037) COMPARED TO 90% UNCHANGED FROM PRE-INTERVENTION IN THE HOME RELAXATION-ONLY GROUP. CONCLUSION: YOGA CLASSES REDUCE SELF-REPORTED FALLS AND IMPROVE BALANCE MEASURES. THE ADDITION OF HOME YOGA EXERCISES DID NOT ENHANCE BENEFIT OVER RELAXATION EXERCISE ONLY. 2017 15 2785 43 YOGA THERAPY AS AN ADJUNCTIVE TREATMENT FOR SCHIZOPHRENIA: A RANDOMIZED, CONTROLLED PILOT STUDY. OBJECTIVES: THERE HAS BEEN LIMITED STUDY OF THERAPEUTIC YOGA AS A COMPLEMENTARY TREATMENT FOR SCHIZOPHRENIA. THIS STUDY INVESTIGATES THE EFFECTS OF A YOGA THERAPY PROGRAM ON SYMPTOMATOLOGY AND QUALITY OF LIFE IN ADULTS WITH SCHIZOPHRENIA IN A STATE PSYCHIATRIC FACILITY. METHODS: IN A RANDOMIZED, CONTROLLED PILOT STUDY, 18 CLINICALLY STABLE PATIENTS (12 MEN AND 6 WOMEN) WITH SCHIZOPHRENIA (MEAN AGE=42+/-13.5) WERE RANDOMIZED TO AN 8-WEEK YOGA THERAPY PROGRAM (YT) AND A WAITLIST GROUP (WL). YT INTERVENTION INCLUDED YOGA POSTURES, BREATHING EXERCISES, AND RELAXATION. AT BASELINE AND AT 8 WEEKS, SYMPTOMATOLOGY WAS MEASURED USING THE POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS). SECONDARY EFFICACY OUTCOMES WERE MEASURED WITH THE WORLD HEALTH ORGANIZATION QUALITY OF LIFE BREF QUESTIONNAIRE (WHOQOL-BREF). RESULTS: THE YT GROUP OBTAINED SIGNIFICANT IMPROVEMENTS IN POSITIVE AND NEGATIVE SYMPTOMS OF SCHIZOPHRENIA SYMPTOMS COMPARED TO WL, INCLUDING PANSS SCORES ON POSITIVE SYNDROME (T=-2.64, P=0.02), NEGATIVE SYNDROME (T=-3.04, P<0.01), GENERAL PSYCHOPATHOLOGY (T=-3.74, P<0.00), ACTIVATION (T=-2.29, P<0.04), PARANOIA (T=-2.89, P<0.01), AND DEPRESSION SUBSCALES (T=-2.62, P<0.02). PANSS TOTAL SCORES ALSO DECREASED FOR THE YT GROUP (T=-4.54, P<0.00). YT HAD IMPROVED PERCEIVED QUALITY OF LIFE IN PHYSICAL (T=2.38, P<0.04) AND PSYCHOLOGIC DOMAINS (T=2.88, P<0.01). CONCLUSIONS: ADULTS WITH SCHIZOPHRENIA BEING TREATED IN A STATE PSYCHIATRIC FACILITY WHO PARTICIPATED IN AN 8-WEEK THERAPEUTIC YOGA PROGRAM SHOWED SIGNIFICANT IMPROVEMENTS IN PSYCHOPATHOLOGY AND QUALITY OF LIFE COMPARED WITH CONTROLS. THE FINDINGS OF THIS STUDY NEED TO BE CONFIRMED IN LARGER, MORE SUFFICIENTLY POWERED STUDIES WITH ACTIVE CONTROL GROUPS. 2011 16 412 36 BLOOD PRESSURE EFFECTS OF YOGA, ALONE OR IN COMBINATION WITH LIFESTYLE MEASURES: RESULTS OF THE LIFESTYLE MODIFICATION AND BLOOD PRESSURE STUDY (LIMBS). THE AUTHORS CONDUCTED A STUDY TO ASSESS THE EFFECTS OF YOGA ON BLOOD PRESSURE (BP). PATIENTS WERE RANDOMIZED TO YOGA (BLOOD PRESSURE EDUCATION PROGRAM [BPEP]), OR A COMBINED PROGRAM (COMBO). AMBULATORY BP WAS MEASURED AT BASELINE AND AT 12 AND 24 WEEKS. DATA ARE PRESENTED FOR ALL ENROLLED PATIENTS (N=137) AND FOR COMPLETERS ONLY (N=90). SYSTOLIC BP (SBP) AND DIASTOLIC BP (DBP) WERE SIGNIFICANTLY DECREASED WITHIN ALL GROUPS AT 12 AND 24 WEEKS (P<.001) FOR ENROLLED PATIENTS AND COMPLETERS. SBP WAS SIGNIFICANTLY REDUCED IN THE YOGA AND COMBO GROUPS AS COMPARED WITH THE BPEP GROUP AT 12 WEEKS IN ALL ENROLLED AND COMPLETERS. SBP DIFFERENCES WERE NO LONGER SIGNIFICANT AT 24 WEEKS BETWEEN GROUPS IN ALL ENROLLED PATIENTS; HOWEVER, THERE WAS A GREATER REDUCTION IN SBP AT 24 WEEKS IN COMPLETERS FAVORING BPEP OVER YOGA. NO DIFFERENCES IN DBP BETWEEN GROUPS OR IN BP BETWEEN THE YOGA AND COMBO GROUPS WERE PRESENT. THE AUTHORS DID NOT OBSERVE AN ADDITIVE BENEFIT FROM COMBINING YOGA WITH BPEP MEASURES. REASONS FOR THIS ARE UNCLEAR AT THIS TIME. BP LOWERING WITH YOGA, HOWEVER, WAS SIMILAR TO THAT ACHIEVED WITH LIFESTYLE MEASURES. 2016 17 270 43 ADD ON YOGA TREATMENT FOR NEGATIVE SYMPTOMS OF SCHIZOPHRENIA: A MULTI-CENTRIC, RANDOMIZED CONTROLLED TRIAL. THE EFFICACY OF ANTIPSYCHOTIC MEDICATIONS IN THE TREATMENT OF NEGATIVE SYMPTOMS OF SCHIZOPHRENIA IS MODEST AT BEST. PRELIMINARY STUDIES SUGGEST THE BENEFICIAL EFFECTS OF ADD ON YOGA, A TRADITIONAL INDIAN PRACTICE, IN THE TREATMENT OF SCHIZOPHRENIA. HENCE, IN THIS STUDY, WE EXAMINED THE EFFICACY OF YOGA AS AN ADD-ON TREATMENT FOR NEGATIVE SYMPTOMS OF SCHIZOPHRENIA IN A RANDOMIZED, WAIT-LIST CONTROLLED DESIGN FROM TWO CLINICAL INSTITUTES IN SOUTH INDIA. 89 PATIENTS (AGE - 34.20 +/- 8.06 YEARS; EDUCATION - 14.22 +/- 2.69 YEARS; 28 FEMALES) WERE RANDOMIZED INTO THE ADD-ON YOGA OR TREATMENT AS USUAL (TAU - WAIT-LIST CONTROL) GROUP. PATIENTS HAD A MEAN ILLNESS DURATION OF 10.97 +/- 7.24 YEARS WITH AN AGE AT ONSET OF 23.34 +/- 5.81 YEARS. CENTRAL BLOCK RANDOMIZATION WAS FOLLOWED TO ENSURE CONCEALED ALLOCATION. PARTICIPANTS RANDOMIZED TO THE YOGA TREATMENT GROUP ATTENDED 12 SUPERVISED YOGA TRAINING SESSIONS OVER TWO WEEKS AND PRACTICED YOGA SESSIONS AT HOME FOR THE SUBSEQUENT 10 WEEKS. 64 PATIENTS COMPLETED THE TRIAL. AN INTENT TO TREAT ANALYSIS WAS CONDUCTED WITH 89 PARTICIPANTS USING A LINEAR MIXED MODEL. IMPROVEMENT IN NEGATIVE SYMPTOMS WAS OUR PRIMARY OUTCOME MEASURE. THE TWO GROUPS WERE MATCHED ON DEMOGRAPHIC VARIABLES AND BASELINE PSYCHOPATHOLOGY SEVERITY. PARTICIPANTS IN THE ADD-ON YOGA GROUP HAD SIGNIFICANTLY GREATER IMPROVEMENT IN NEGATIVE SYMPTOMS (SANS BASELINE: 49.13 +/- 2.30; 12-WEEKS FOLLOW UP: 31.55 +/- 2.53) COMPARED TO THE TAU GROUP (SANS BASELINE: 51.22 +/- 2.40; 12-WEEKS FOLLOW UP: 45.30 +/- 2.93; T = 3.36; P = 0.006; COHEN'S D-0.65). THE CURRENT STUDY FINDINGS SUGGEST THE EFFICACY OF YOGA AS AN ADD-ON TREATMENT FOR NEGATIVE SYMPTOMS OF SCHIZOPHRENIA. THE EFFECTIVENESS OF YOGA PRACTICE AS A REGULAR CLINICAL INTERVENTION FOR PATIENTS NEEDS TO BE EXPLORED IN FUTURE STUDIES BY INTEGRATING YOGA SERVICES ALONG WITH OTHER CLINICAL SERVICES. 2021 18 1818 40 PROSPECTIVE RANDOMIZED TRIAL OF STANDARD ANTIEMETIC THERAPY WITH YOGA VERSUS STANDARD ANTIEMETIC THERAPY ALONE FOR HIGHLY EMETOGENIC CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN SOUTH ASIAN POPULATION. AIM/BACKGROUND: CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) IS ONE OF THE MOST DISTRESSING SIDE EFFECTS OF HIGHLY EMETOGENIC CHEMOTHERAPY REGIMENS. THERE HAVE BEEN CONTINUOUS EFFORTS IN THE DIRECTION TO CONTROL CINV BY MANY INVESTIGATORS. MATERIALS AND METHODS: RANDOMLY SELECTED PATIENTS WERE THOSE RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY REGIMEN GROUPED INTO YOGA AND STANDARD ANTIEMETIC THERAPY (N = 50) JUST BEFORE RECEIVING CHEMOTHERAPY AND CONTINUED FOR THE FOLLOWING DAYS AND OTHER GROUP (N = 50) RECEIVED ONLY THE STANDARD ANTIEMETIC AGENT. BOTH THE GROUPS WERE ASSESSED, FOLLOWED FOR ACUTE AND DELAYED ONSET OF CHEMOTHERAPY-INDUCED AND ANTICIPATORY NAUSEA AND VOMITING USING RADIATION THERAPY ONCOLOGY GROUP GRADING FOR THE SAME. WE ALSO ASSESSED THE QUALITY OF LIFE OF THE PATIENT USING THE FUNCTIONAL ASSESSMENT OF CANCER THERAPY-GENERAL QUESTIONNAIRE. RESULTS: THE MEDIAN AGE GROUP OF THE PATIENTS WAS 51 YEARS WITH MALE:FEMALE RATIO 2:1, THE EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG) PERFORMANCE STATUS WAS 0/1 IN 38% OF THE SELECTED POPULATION, WHILE ECOG 2 IN 62% OF THE PATIENTS. IN YOGA ARM, INSIGNIFICANT REDUCTION IN CHEMOTHERAPY-INDUCED NAUSEA (90% VS. 78%, P = 0.35) AND BUT SIGNIFICANT REDUCTION IN VOMITING (42% VS. 22%, P =0.01) WAS OBSERVED AS COMPARED TO THE STANDARD ANTIEMETICS ONLY ARM. THERE WAS A SIGNIFICANT REDUCTION IN GRADE 2 AND 3 NAUSEA (84% VS. 38% P < 0.01) AND VOMITING (14% VS. 0% P < 0.01). QUALITY OF LIFE IS ALSO SIGNIFICANTLY IMPROVED IN THE YOGA ARM, ESPECIALLY IN THE ECOG 2 PERFORMANCE STATUS. CONCLUSIONS: THIS STUDY CONCLUDES THAT YOGA ALONG WITH STANDARD ANTIEMETIC MEDICATION SHOULD BE A PART OF THE MANAGEMENT PLAN FOR THE CANCER PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY. 2019 19 1292 46 GROUP YOGA EFFECTS ON CANCER PATIENT AND CAREGIVER SYMPTOM DISTRESS: ASSESSMENT OF SELF-REPORTED SYMPTOMS AT A COMPREHENSIVE CANCER CENTER. BACKGROUND: COMPLEMENTARY AND INTEGRATIVE HEALTH APPROACHES SUCH AS YOGA PROVIDE SUPPORT FOR PSYCHOSOCIAL HEALTH. WE EXPLORED THE EFFECTS OF GROUP-BASED YOGA CLASSES OFFERED THROUGH AN INTEGRATIVE MEDICINE CENTER AT A COMPREHENSIVE CANCER CENTER. METHODS: PATIENTS AND CAREGIVERS HAD ACCESS TO TWO YOGA GROUP CLASSES: A LOWER INTENSITY (YLOW) OR HIGHER INTENSITY (YHIGH) CLASS. PARTICIPANTS COMPLETED THE EDMONTON SYMPTOM ASSESSMENT SYSTEM (ESAS; SCALE 0-10, 10 MOST SEVERE) IMMEDIATELY BEFORE AND AFTER THE CLASS. ESAS SUBSCALES ANALYZED INCLUDED GLOBAL (GDS; SCORE 0-90), PHYSICAL (PHS; 0-60), AND PSYCHOLOGICAL DISTRESS (PSS; 0-20). DATA WERE ANALYZED EXAMINING PRE-YOGA AND POST-YOGA SYMPTOM SCORES USING PAIRED T-TESTS AND BETWEEN TYPES OF CLASSES USING ANOVAS. RESULTS: FROM JULY 18, 2016, TO AUGUST 8, 2017, 282 UNIQUE PARTICIPANTS (205 PATIENTS, 77 CAREGIVERS; 85% FEMALE; AGES 20-79 YEARS) ATTENDED ONE OR MORE YOGA GROUPS (MEAN 2.3). FOR ALL PARTICIPANTS, WE OBSERVED CLINICALLY SIGNIFICANT REDUCTION/IMPROVEMENT IN GDS, PHS, AND PSS SCORES AND IN SYMPTOMS (ESAS DECREASE >/=1; MEANS) OF ANXIETY, FATIGUE, WELL-BEING, DEPRESSION, APPETITE, DROWSINESS, AND SLEEP. CLINICALLY SIGNIFICANT IMPROVEMENT FOR BOTH PATIENTS AND CAREGIVERS WAS OBSERVED FOR ANXIETY, DEPRESSION, FATIGUE, WELL-BEING, AND ALL ESAS SUBSCALES. COMPARING YOGA GROUPS, YLOW CONTRIBUTED TO GREATER IMPROVEMENT IN SLEEP VERSUS YHIGH (-1.33 VS -0.50, P = .054). IMPROVEMENT IN FATIGUE FOR YLOW WAS THE GREATEST MEAN CHANGE (YLOW -2.12). CONCLUSION: A SINGLE YOGA GROUP CLASS RESULTED IN CLINICALLY MEANINGFUL IMPROVEMENT OF MULTIPLE SELF-REPORTED SYMPTOMS. FURTHER RESEARCH IS NEEDED TO BETTER UNDERSTAND HOW YOGA CLASS CONTENT, INTENSITY, AND DURATION CAN AFFECT OUTCOMES. 2018 20 822 37 EFFECT OF YOGA ON FEV1, 6-MINUTE WALK DISTANCE (6-MWD) AND QUALITY OF LIFE IN PATIENTS WITH COPD GROUP B. INTRODUCTION: YOGA IS USED IN THE TREATMENT OF VARIOUS DISEASES, INCLUDING CHRONIC OBSTRUCTIVE PULMONARY DISEASE. HOWEVER, NO STUDIES HAVE ASSESSED THE EFFECT OF YOGA ON COPD PATIENTS IN INDONESIA. THE DIFFERENCE BETWEEN THIS STUDY AND SIMILAR STUDIES COMPLETED IN OTHER COUNTRIES LIES IN THE TYPE OF YOGA EXERCISES COMPLETED, THE METHOD IN WHICH THEY WERE COMPLETED, AND IN CERTAIN, UNIQUE DEMOGRAPHIC CHARACTERISTICS. THIS STUDY AIMS TO ANALYZE THE EFFECT OF YOGA ON FEV1, 6-MINUTE WALK DISTANCE, AND QUALITY OF LIFE IN PATIENTS WITH COPD GROUP B IN INDONESIA. MATERIAL AND METHODS: THIS ARTICLE REFLECTS RESEARCH DONE IN THE FORM OF AN EXPERIMENTAL STUDY USING ARANDOMIZED CONTROLLED TRIAL WITH PRE AND POST-TEST CONTROL GROUP DESIGN. THE SAMPLES WERE DIVIDED INTO 2 GROUPS: THE TREATMENT GROUP (YOGA PRACTICE FOR 1 HOUR, 2 TIMES AWEEK FOR 12 WEEKS) AND THE CONTROL GROUP (UNTREATED WITH YOGA, GIVEN LUNG REHABILITATION BROCHURE). ASSESSMENT OF THE EFFECT OF YOGA EXERCISES ON LUNG FUNCTION PARAMETERS (FEV1), 6-MINUTE WALK DISTANCE AND QUALITY OF LIFE WERE USED USING SGRQ QUESTIONNAIRES IN COPD GROUP B. RESULTS: 33 COPD PATIENTS FULFILLED THE INCLUSION CRITERIA. 30 PATIENTS COMPLETED THE STUDY. PRE AND POST YOGA RESULTS WERE EVALU-ATED IN THE TREATMENT GROUP VERSUS THE CONTROL GROUP AND THEN FURTHER ASSESSED USING STATISTICAL TESTS. THERE WAS ASIGNIFICANT IN-CREASE IN FEV1, 6-MWD AND QUALITY OF LIFE USING ASGRQ QUESTIONNAIRE AFTER 12 WEEKS OF YOGA (P < 0.05) AS WELL AS AASIGNIFICANT CHANGE IN FEV1, 6-MWD AND QUALITY OF LIFE IN THE TREATMENT GROUP (P < 0.05) WHEN COMPARED WITH THE CONTROL GROUP (P > 0.05). CONCLUSIONS: YOGA AFFECTS FEV1, 6-MWD, AND QUALITY OF LIFE IN PATIENTS WITH GROUP B COPD. 2019